Mosaic ImmunoEngineering, Inc. (OTCPK: CPMV)
Health Care · Biotechnology · US
$0.06
-87.80% today · -88.6% 1Y
Mosaic ImmunoEngineering, Inc. (OTCPK: CPMV) operates in the Biotechnology industry within the Health Care sector. The company is valued at $441.77K and employs 7 people.
Over the last twelve months the share price has lost 88.6%, trading between 0.05 and 1.05.
Tweenvest scores Mosaic ImmunoEngineering, Inc. across four factors: quality 5/100. Its strongest factor is quality.
CPMV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $441.77K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- -0.81
- 52-week high
- $1.05
- 52-week low
- $0.05
- Avg volume (3M)
- —
- Shares outstanding
- 7.24M
- Employees
- 7
- Next earnings
- —
About Mosaic ImmunoEngineering, Inc.
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
- ISIN
- US61945M1018
- Founded
- 2020
- Listed since
- Jan 2, 2013
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.